Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 15,693 shares at $20.61 ($324K) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($324k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.61 | 15,000 | $309K | 95.5% |
| 2 | $21.15 | 693 | $15K | 4.5% |
| Total | $20.63 avg | 15,693 | $324K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-18 | $494K | — | Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |